[F-18] Fluorodeoxyglucose Positron Emission Tomography as a Tool for Early Recognition of Incomplete Tumor Destruction after Radiofrequency Ablation for Liver Metastases

Journal of Surgical Oncology

Volumn 84, Issue 4, 2003, Pages 215-223

  Donckier, Vincent ^a   Van Laethem, Jean Luc ^a   Goldman, Serge ^a   Van Gansbeke, Daniel ^b   Feron, Pascale ^a   Ickx, Brigitte ^a   Wikler, David ^a   Gelin, Michel ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Destruction; Evaluation; Hepatic; Local; Malignancy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER RECURRENCE; CATHETER ABLATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; HYPERMETABOLISM; INTERMETHOD COMPARISON; LIVER METASTASIS; MEDICAL ASSESSMENT; MICROVASCULARIZATION; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR CELL;

BREAST NEOPLASMS; CATHETER ABLATION; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0344012085     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10314     Document Type: Article

References (35)

1. Adson MA, Van Heerden JA, Adson MH, et al.: Resection of hepatic metastases from colorectal cancer. Arch Surg 1984;119:647-651.
2. Scheele J, Stangl R, Altendorf-Hofman A. Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history. Br J Surg 1990;77:1241-1246.
3. Nordlinger B, Guiget M, Vaillant JC, et al.: Surgical resection of colorectal carcinoma metastases of the liver. A prognostic scoring system to improve case selection, based on 1,568 patients. Cancer 1996;77:1254-1262.
4. Rees M, Plant G, Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 1997;84:1136-1140.
5. Fong Y, Cohen AM, Fortner JG, et al.: Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-946.
6. Fong Y, Fortner J, Sun RL, et al.: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1,001 consecutive cases. Ann Surg 1999;230:309-318.
7. Jarnagin WR, Fong Y, Ky A, et al.: Liver resection for metastatic colorectal cancer: Assessing the risk of occult irresectable disease. J Am Coll Surg 1999;188:33-42.
8. Seki T, Wakabayashi M, Nakagawa T, et al.: Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: A pilot clinical study. Am J Gastroenterol 1999;94:322-327.
9. Yamashita Y, Sakai T, Maekawa T, et al.: Thoracoscopic transdiaphragmatic microwave coagulation therapy for a liver tumor. Surg Endosc 1998;12:1254-1258.
10. Ishii H, Okada S, Nose H, et al.: Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1996;77:1792-1796.
11. Liviraghi T, Bolondi L, Lazzaroni S, et al.: Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Cancer 1992;69:925-929.
12. McCarty TM, Kuhn JA. Cryosurgery for liver tumors. Oncology 1998;12:979-987.
13. Tandam VR, Harmantas A, Gallinger S. Long-term survival after hepatic cryosurgery versus surgical resection for metastatic colorectal carcinoma: A critical review of the literature. Can J Surg 1997;40:175-181.
14. Curley SA, Izzo F, Delrio P, et al.: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Ann Surg 1999;230:1-8.
15. Wood TF, Rose DM, Chung M et al.: Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications. Ann Surg Oncol 2000;7:593-600.
16. Jiao LR, Hansen P, Havlic R, et al.: Radiofrequency ablation for primary and secondary liver tumours. Am J Surg 1999;177:303-306.
17. Bilchik AJ, Wood TF, Allegra D, et al.: Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms. Arch Surg 2000;135:657-664.
18. Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001;6:14-23.
19. Rose SC, Hassanein TI, Easter DW, et al.: Value of three-dimensional US for optimizing guidance for ablating focal liver tumors. J Vasc Interv Radiol 2001;12:507-515.
20. Boaz TL, Lewin JS, Chung YC, et al.: MR monitoring of MR-guided radiofrequency thermal ablation of normal liver in an animal model. J Magn Reson Imaging 1998;8:64-69.
21. Yamasaki T, Kurokawa F, Shirahashi H, et al.: Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance in patients with hepatocellular carcinoma. Cancer 2001;91:1342-1348.
22. Rossi S, Buscarini E, Garbagnati F, et al.: Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. Am J Roent 1998;170:1015-1022.
23. Curley SA, Izzo F, Ellis LM, et al.: Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-389.
24. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al.: Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings. Radiology 1998;206:755-760.
25. Ruers TJ, Langenhoff BS, Neeleman N, et al.: Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: A prospective study. J Clin Oncol 2002;20:388-395.
26. Delbeke D, Vitola JV, Sandler MP, et al.: Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997;38:1196-1201.
27. Meta J, Seltzer M, Schiepers C, et al.: Impact of (18)-FDG PET on managing patients with colorectal cancer: The referring physician's perspective. J Nucl Med 2001;42:586-590.
28. Brix G, Zaers J, Adam LE, et al.: Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 1997;38:1614-1623.
29. Catalano O, Espositio M, Nunzita A, et al.: Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma. Abdom Imaging 2000;25:607-614.
30. Tsuda M, Majima K, Yamada T, et al.: Hepatocellular carcinoma after radiofrequency ablation therapy: Dynamic CT evaluation of treatment. Clin Imaging 2001;25:409-415.
31. Chopra S, Dodd GD III, Chintapalli KN, et al.: Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: Spectrum of findings on dual-phase contrast-enhanced CT. AJR Am J Roentgenol 2001;177:381-387.
32. Rossi S, Garbagnati F, Lencioni R, et al.: Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000;217:119-126.
33. Beets G, Penninckx F, Schiepers C, et al.: Clinical value of whole body positron emission tomography (18F) fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 1994;81:1666-1670.
34. Zhuang H, Sinha P, Pourdehnad M, et al.: The role of positron emission tomography with fluorine-18-fluorodeoxyglucose in identifying colorectal metastases to liver. Nucl Med Commun 2000;21:793-798.
35. Kemeny N, Gonen M, Sullivan D, et al.: Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001;19:2687-2695.